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Abstract
Rationale By enhancing brain anandamide tone, inhibitors
of fatty acid amide hydrolase (FAAH) induce anxiolytic-
like effects in rodents and enhance brain serotonergic
transmission. Mice lacking the faah gene (FAAH
−/−) show
higher anandamide levels. However, their emotional phe-
notype is still debated and their brain serotonergic tone
remained unexplored.
Objectives and methods In this study, we tested FAAH
−/−
mice in the social interaction and the open field tests
performed under different lighting conditions (dim and
bright) since variations of the experimental context were
proposed to explain opposite findings. Moreover, by
microdialysis performed under dim light, we analyzed their
serotonergic transmission in frontal cortex (FC) and ventral
hippocampus (vHIPP).
Results In both light conditions, FAAH
−/− mice showed
reduced emotionality, compared to wt controls, as sug-
gested by the increased rearing and reduced thigmotaxis
displayed in the open field and by the longer time spent in
social interaction. Basal serotonergic tone was higher in the
FC of mutant mice as compared to control mice, while no
difference was observed in the vHIPP. K
+-induced depo-
larization produced similar increases of serotonin in both
areas of both genotypes. An acute treatment with the CB1
antagonist rimonabant completely abolished the emotional
phenotype of FAAH
−/− mice and prevented the K
+-
stimulated release of serotonin in their FC and vHIPP,
without producing any effect in wt mice.
Conclusions Our results support the role of FAAH in the
regulation of emotional reactivity and suggest that
anandamide-mediated hyperactivation of CB1 is responsi-
ble for the emotional phenotype of FAAH
−/− mice and for
their enhanced serotonergic tone.
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Introduction
Brain anandamide tone plays important roles in the
modulation of emotionality and mood through the activa-
tion of cannabinoid receptor type 1 (CB1). The fatty acid
amide hydrolase (FAAH) is the critical regulator of
anandamide levels (Freund et al. 2003). In accordance,
mutant mice lacking faah gene (FAAH
−/− mice) show
various signs of exaggerated anandamide tone, such as
increased nociceptive threshold, enhanced memory extinc-
tion and increased sensitivity to the effects of exogenously
administered anandamide (Cravatt et al. 2001; Varvel et al.
2007).
Many observations indicate that FAAH may serve as a
new target for the treatment of anxiety and mood disorders
(Gaetani et al. 2003, 2009). In fact, the administration of
the FAAH inhibitor URB597 produced anxiolytic- and
antidepressant-like effects in several behavioural tests for
rodents (Kathuria et al. 2003; Naidu et al. 2007; Patel and
Hillard 2006; Moreira et al. 2008). These effects were
accompanied by elevations of brain anandamide levels
(Kathuria et al. 2003) and stimulation of monoaminergic
neuronal activity in brain regions controlling mood and
emotionality (Berton and Nestler 2006; Gobbi et al. 2005).
In accordance with these results, FAAH
−/− mice
exhibited reduced anxiety-like behaviour in the elevated
plus maze and the light–dark tests (Moreira et al. 2008).
Their phenotype was reversed by the systemic administra-
tion of the CB1 antagonist rimonabant. Similarly, rimona-
bant antagonized the effects of URB597 in rodents, thus
suggesting an involvement of CB1-receptor-mediated sig-
nalling. Opposite observations on FAAH
−/− mice were
reported by Naidu et al. (2007). Differences in the
experimental contexts have been proposed as key factors
determining such discrepancies (Moreira et al. 2008). In
keeping with this hypothesis, the anxiolytic effects of
URB597 were mostly evident under aversive testing
condition, i.e. when rats had no habituation to the
experimental room or were not previously handled or when
a bright light illuminated the testing environment (Naidu et
al. 2007; Naderi et al. 2008; Haller et al. 2009).
In this study, we explored whether the emotional
phenotype of FAAH
−/− mice can vary with the experimental
context. To this aim, we evaluated male wild-type (wt) and
FAAH
−/− mice in two different ethological tests of anxiety,
the open field test and the social interaction test. Since a
bright illumination of the behavioural apparatus is well
established to increase fear in rodents (Valle 1970), both
tests were performed in a nonfamiliar environment illumi-
nated with either dim or bright lights. Moreover, consider-
ing the likelihood of finding a reduced emotionality in
FAAH
−/− mice accordingly with the observation reported in
the literature, we performed both tests during the light
phase (resting phase) when, in general, rodents show a
higher anxiety-related behaviour and are more sensitive to a
new environmental challenge (Bertoglio and Carobrez
2002; Roedel et al. 2006).
To further characterize the emotional phenotype of
FAAH
−/− mice, we searched for a neurochemical correlate
in their brain serotonin (5-HT) tone, as previous studies
showed an endophenotypic augmentation of spontaneous 5-
HT neuronal discharge activity (Bambico et al. 2009)i n
these mice. Therefore, by in vivo microdialysis, we
analyzed basal and K
+-stimulated 5-HT extracellular levels
in the frontal cortex (FC) and ventral hippocampus
(vHIPP), two regions receiving 5-HT inputs from the raphe
nuclei and highly involved in the regulation of anxiety-
related behaviour. In all experiments, the involvement of
CB1 receptor activation was tested by evaluating the effects
of rimonabant administration.
Materials and methods
Animals
All experiments were carried out on male adult FAAH
knockout (FAAH
−/−) mice and their wt counterparts
(FAAH
+/+). All mice used were from the F9 generation,
weighed 30–35 g during the time of the experiments.
FAAH
−/− mice were generated as previously described
(Cravatt et al. 2001) and were backcrossed into C57BL6/6 J
background. Mutant and wt mice were bred and maintained
in the animal facilities of the University of California
(Irvine, CA, USA) under standard conditions (12:12 light–
466 Psychopharmacology (2011) 214:465–476dark cycle, lights on at 07:30; temperature at 20±2°C; 50–
60% relative humidity, ad libitum access to food and water)
until maturation. Thereafter, a batch of the colony was
transported to the animal facilities of the University of
Foggia, where animals were maintained under similar
conditions and group-housed (four to six per cage). One
week prior to the behavioural tests, the mice were single-
housed. Experimental procedures commenced about
3 months after arrival in the laboratory facility when the
mice were approximately 6–7 months old. All experiments
on FAAH
−/− mice were performed with age-matched wt
controls (Bambico et al. 2010).
All the experimental procedures met the Italian National
Laws (DL 116/92) and the European Communities Council
Directive (86/609/EEC). All efforts were made to minimize
the number of animals used in the study and their suffering.
Chemicals
N-Piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-
methyl-pyrazolecarboxamide (rimonabant) was dissolved in
5% Tween–80/5% polyethylene glycol/saline (by volume)
and injected intraperitoneally (i.p.) in a volume of 10 ml/kg
of body weight. All HPLC chemicals were from Sigma-
Aldrich (Milan, Italy) and Levanchimica (Bari, Italy).
Behavioural testing
Open field test
The open field test is one of the most popular tests for the
study of emotionality in rodents. The number of risk
assessment postures directed to the open field provides a
good measure of the approach response toward novelty that
is exploration. Anxiety behaviour in the open field is
triggered by two factors: individual testing (the animal is
separated from its social group) and agoraphobia (as the
arena is very large relative to the animal’s breeding or
natural environment) (Prut and Belzung 2003).
All behavioural tests were performed between 08:00 and
14:00. The apparatus was illuminated either by four 40-W
neon lamps (bright light condition, 200 lx at the arena
level) or by a red lamp of 40 W (dim light condition, 1 lx at
the arena level). The open field apparatus consisted of a
square arena (28×28-cm white Plexiglas box with 15-cm-
high walls) with the floor divided into 16 squares (7×7 cm)
by black lines drawing over it. On the day of experiments, wt
mice (n=9–12 animals per treatment group) and FAAH
−/−
mice (n=14–16 animals per treatment group) were trans-
ferred to the experimental room immediately before testing.
Each mouse received a single i.p. injection of rimonabant
(1 mg/kg) or vehicle and 25 min later placed at the centre of
the arena, where it was left undisturbed for 5 min. The mice
were monitored and videotaped with a camera (Canon
MV750i) mounted on a tripod about 1 m above the centre
of the arena floor. The following ethological parameters
were measured by an observer unaware of genotypes and
treatments: (1) the frequency and the duration of rearing
(including wall rearing), (2) the thigmotaxis (time spent in
the corners and along the walls of the arena), (3) the time
spent in self-grooming (wiping, licking, combing or
scratching any part of its own body) and (4) locomotor
activity (total number of squares crossed with both
forepaws).
Social interaction test
Immediately following the open field test, each mouse was
left in the arena to undergo the social interaction test. An
unfamiliar conspecific juvenile partner (15–17 g) was placed
at the centre of the arena and the mice were video-recorded
undisturbed for a 5-min period (File and Seth 2003).
The social interaction test is the first animal test of
anxiety that endeavoured to use ethologically relevant
sources of anxiety and to use a natural form of behaviour
as the dependent measure. The endpoints analyzed were the
latency to the first social contact and the time spent by the
tested mice in social interaction measured as the total time
spent sniffing, following, grooming, mounting and crawling
under or over the partner. Passive interaction (when the
tested mouse sat or lied with body contact, but without
interaction, with the juvenile partner) was not included. An
increase in social interaction is indicative of an anxiolytic
effect, whereas a specific decrease in social interaction
indicates an anxiogenic effect (File and Seth 2003).
Motor activity for four consecutive days
To investigate the habituation profile of spontaneous motor
activity in the open field test, wt mice (n=12) and FAAH
−/−
mice (n=15) were repeatedly subjected to the open field
test for four consecutive days, being transferred to the
experimental room just prior to the daily session and
returned to their housing room at the end of the session.
Each day, the mice were left undisturbed in the arena for
30 min under a dim light condition and their motor activity
was measured across 5-min time bins. The overall motor
activity was assessed as the total number of squares crossed
with both forepaws (horizontal movement) and the fre-
quency and the duration of rearing events (vertical
movement).
Microdialysis in freely moving mice
Mice (n=5–7 animals per group) were anaesthetized by
equithensin (3 ml/kg, i.p.) and double-implanted with a
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Sweden), vertically placed into the right vHIPP (anterior–
posterior, −3.0 mm; lateral, +3.0 mm; ventral, −1.8 mm
from bregma), and a hand-made microdialysis linear
probe (AN69 Hospal S.p.A; 20 kDa cutoff; 3-mm
membrane length), horizontally placed into the FC
(anterior–posterior, +5.9 mm; ventral, −4.0 mm from the
interaural line) according to the stereotaxic atlas of
Franklin and Paxinos (1997). Two days after surgery, the
CMA/7 probe (6 kDa cutoff; 2-mm membrane length) was
inserted and dialyses were carried out in awake freely
moving mice, perfusing the probes with Krebs–Ringer
phosphate buffer at a flow rate of 1 μl/min and collecting
dialysates every 30 min. The constituents of the buffer were
(in mM) 145 NaCl, 2.7 KCl, 1 MgCl2, 1.2 CaCl2 and 2
Na2HPO4, at pH 7.4.
After a 120-min stabilization period, four samples were
collected from each probe to establish stable baseline levels
of 5-HT. Thereafter, mice were treated with rimonabant
(1 mg/kg, i.p.) or vehicle (time, zero) and six samples were
further collected. At 180 min after the acute treatment, the
mice were subjected to a second i.p. administration of the
same drug received before and the probes were transiently
perfused for 30 min with KCl (100 mM)-enriched Krebs–
Ringer buffer. Four samples were further collected when
the perfusion was returned to the previous Krebs–Ringer
buffer. After the completion of the microdialysis, each
probe placement was verified histologically.
HPLC analysis
The levels of 5-HT were determined by microbore HPLC
using a SphereClone 150×2-mm column (3 μm packing)
with a Unijet cell (BAS, Bioanalytical Systems, Kenilworth
Warwickshire, UK) equipped with a 6-mm-diameter glassy
carbon electrode (set at +650 mV) and connected to an
electrochemical amperometric detector (INTRO, Antec
Leyden, The Netherlands). The flow rate of the mobile
phase [85 mM sodium acetate, 0.34 mM EDTA, 15 mM
sodium chloride, 0.81 mM octanesulphonic acid sodium
salt, 2% acetonitrile (v/v), 9% methanol (v/v), pH 4.85] was
220 μl/min and the total runtime was 40 min.
Statistical analysis
All data were expressed as mean±SEM. Within-group
variability was analysed through Levene test for homoge-
neity of variances. Most of the data from open field and
social interaction tests failed to meet the homoscedasticity
assumption; therefore, they were analyzed by Kruskal–
Wallis ANOVA followed by orthogonal chi-square (χ
2)
partitioning to test the main effects of light (L), genotype
(G), treatment (T) and the interactions L×G, L×T, G×T
and L×T×G. Mann–Whitney U test with Bonferroni’s
correction was used as post hoc test for multiple
comparisons.
The results obtained analyzing the locomotor activity,
rearing frequency and rearing duration for 4 consecutive
days and the results from microdialysis experiments
resulted homoscedastic and were analyzed by two-way
ANOVA for repeated measures, with “time” as the within
variable and “genotype” or “treatment” as the between
variable, depending from the experimental design. Vio-
lations of the sphericity assumption were corrected using
the Greenhouse–Geisser epsilon correction to adjust the
degrees of freedom. Dunnett’s post hoc comparisons
were used where appropriate. Overall, basal 5-HT levels
were calculated as marginal means of the first four
dialysate samples and were analysed by two-tailed
Student’st test. The threshold for statistical significance
was set at P<0.05.
Results
FAAH
−/− mice show reduced emotional reactivity
in the open field test
The emotional phenotype of FAAH
−/− mice was first tested
in a nonsocial context using the open field test, a well-
established task to evaluate fear reactivity (Choleris et al.
2001). The results obtained by the nonparametric statistical
analysis aimed to test the main effects of light (L), genotype
(G), treatment (T), and the interactions L×G, L×T, G×T
and L×T×G are reported in Table 1.
L G T L×G L×T G×T L×G×T
Rearing frequency χ
2 12.93*** 16.12*** 20.66*** n.s. n.s. n.s. n.s.
Rearing duration χ
2 6.88*** 12.31*** 25.48*** n.s. n.s. n.s. n.s.
Thigmotaxis χ
2 45.12*** 7.83** 7.51** n.s. n.s. n.s. n.s.
Grooming χ
2 15.32*** 5.80* 7.55** n.s. 4.04* n.s. n.s.
Locomotor activity χ
2 34.26*** 25.89*** n.s. n.s. n.s. n.s. n.s.
Social interaction χ
2 8.15** 4.46* 26.20*** n.s. n.s. 11.77** n.s.
Table 1 Results from the non-
parametric statistical analysis of
data obtained from the open
field and social interaction tests
L light, G genotype, T treatment,
χ
2 deriving from the orthogonal
partitioning of Kruskal–Wallis H,
n.s. P>0.05 (n=9–16 per group)
*P<0.05; **P<0.01; ***P<0.001
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both the rearing frequency and the rearing duration were
higher in FAAH
−/− than in wt mice (+264% and +440%,
respectively; Fig. 1a, b). Such difference disappeared in
mice treated with rimonabant and was attenuated in mice
exposed to the bright light. In fact, in this condition, only
rearing duration remained significantly higher in FAAH
−/−
mice with respect to control mice (+483%).
As for thigmotaxis, FAAH
−/− mice spent significantly
less time in the corners and along the walls compared to wt
mice (Fig. 1c). This difference was evident under both dim
and bright light conditions (−38% and −27% in FAAH
−/−
mice, respectively) but was abolished by rimonabant
treatment. As expected, the bright light caused a significant
increase of thigmotaxis in both genotypes (+77% in wt and
+107% in FAAH
−/− mice).
The occurrence of grooming behaviour was similar in
both genotypes, when mice were injected with vehicle and
tested under a dim light (Fig. 1d). However, either
rimonabant treatment in dim light condition or the exposure
Fig. 1 Effects of the CB1 antagonist rimonabant (rim) on rearing
frequency (a), rearing duration (b), thigmotaxis (c), grooming (d),
locomotor activity and (e) of FAAH
−/− (black bar) and wt (white bar)
mice tested in the open field under dim (grey panel)o rb r i g h t( open
panel) light conditions. Data are expressed as mean±SEM (n=9–16 per
group). *P<0.05 (Mann–Whitney U test with Bonferroni’s correction)
Psychopharmacology (2011) 214:465–476 469tothe brightlight condition producedanincreaseofgrooming
behaviour in FAAH
−/− mice (+238% and +339%, respec-
tively), but not in wt mice.
A further difference between the two genotypes was
found whenwemeasured locomotor activityduringthe 5-min
period of the open field test (Fig. 1e). In particular, although
the bright light condition reduced the locomotor activity in
mice of both genotypes, the mutant mice showed a signifi-
cantly higher number of crossings with respect to wt mice
when tested either in dim or bright light (+118% and +112%).
Rimonabant treatment did not affect the locomotor activity in
both genotypes.
FAAH
−/− mice show reduced emotional reactivity
in the social interaction test
We further evaluated the behavioural phenotype of FAAH
−/−
mice in a social context, using the social interaction test, which
is sensitive to a number of environmental and physiological
factors that can affect anxiety (File and Seth 2003).
The results regarding nonparametric analysis aiming to
test the main effects of light (L), genotype (G), treatment
(T) and the interactions L×G, L×T, G×T and L×T×G are
reported in Table 1.
An evident phenotypical difference between the two
genotypes was observed in this test. In fact, although the
animals from all groups showed similar latencies to the first
contact with the conspecific (Fig. 2a), compared to wt,
FAAH
−/− mice spent significantly more time engaged in
active interaction, both when the test was performed in dim
light (+83%) and when mice were tested in bright light
(+106%) (Fig. 2b). Rimonabant treatment did not affect the
social interaction in wt mice, regardless of the lighting
condition, whereas it significantly reduced the social activity
of FAAH
−/− mice, tested either in dim (−65%) or in bright
light (−66%), thus abolishing the behavioural differences
between the two genotypes. Bright lighting condition
significantly reduced the social interaction activity of
FAAH
−/− mice, without affecting the behaviour in wt mice.
FAAH
−/− mice show a normal habituation profile
of spontaneous motor activity
The higher locomotor activity displayed by FAAH
−/− mice
during the 5-min open field test raised the question of
whether it might be an indicator of a better response to
novelty and stressing situation or the consequence of a
mere general hyperactive behaviour. Addressing this issue
was fundamental to interpret the results obtained from the
social interaction test. In fact, if FAAH
−/− mice were
generally hyperactive, the longer time spent in social
interaction could not necessarily reflect a lower emotional
reactivity with respect to wt mice. To explore these
possibilities, we repeatedly subjected the mice to a 30-min
open field test in dim light for four consecutive days to
analyse their habituation profile in a novel environment.
In each day, a regular habituation profile of spontaneous
locomotor activity was observed in both genotypes
(Fig. 3a). The two-way ANOVA for repeated measures
revealed that the locomotor activity of FAAH
−/− mice was
higher than of wt mice only during the first day, whilst no
difference was observed during the following days (1st day:
main effect of time F5,125=16.06, P<0.0001; main effect of
genotype F1,25=6.37, P<0.05; interaction between effects
of time and genotype F5,125=0.777, n.s.; 2nd day: main
effect of time F5,125=10.342, P<0.0001; 3rd day: main
effect of time F5,125=8.584, P<0.0001; 4th day: main effect
of time F5,125=9.427, P<0.0001).
Moreover, the analysis of overall rearing activity (often
referred as vertical movement) confirmed the genotype
difference only during the first day of the open field, whilst
no difference was observed during the following days
(Fig. 3b, c). In fact, FAAH
−/− mice had higher rearing
frequency (genotype difference, F1,125=7.076, P<0.05) and
Fig. 2 Effects of the CB1 antagonist rimonabant (rim) on the latency
to the first social contact (a) and on the time spent in social interaction
(b) displayed by FAAH
−/− (black bar) and wt (white bar) mice in the
social interaction test under dim (grey panel) or bright (open panel)
light conditions. Data are expressed as mean±SEM (n=9–16 per
group). *P<0.05 (Mann–Whitney U test with Bonferroni’s correction)
470 Psychopharmacology (2011) 214:465–476rearing duration (genotype difference, F1,125=7.051, P<
0.05) compared to wt mice.
FAAH
−/− mice show enhanced 5-HT-ergic tone in FC
and higher sensitivity to rimonabant effects
After a 2-h stabilization period, the basal extracellular levels of
5-HTreached a steady state in both FC and vHIPP of all mice.
The overall basal 5-HT levels (calculated as the marginal
means of the first four dialysates) in the FC of FAAH
−/− mice
(1.93±0.04 ng/ml) resulted significantly (t9=33.15, P<
0.0001) higher compared to wt mice (0.42±0.01 ng/ml;
Fig. 4a, b). Conversely, basal 5-HT level in vHIPP did not
differ (t9=1.207, n.s.) between the two genotypes (wt: 0.44±
0.02 ng/ml; FAAH
−/−: 0.46±0.01 ng/ml; Fig. 4c, d).
Moreover, in both genotypes, the first systemic admin-
istration of rimonabant (1 mg/kg, i.p.) did not alter the basal
extracellular 5-HT levels either in FC (Fig. 4a, b) or vHIPP
(Fig. 4c, d) with respect to animals of the same genotype
treated with vehicle.
K
+-stimulation significantly increased the extracellular
5-HT release in the FC (main effect of time: F5,45=40.166,
P<0.001; Fig. 4a, b) and vHIPP (main effect of time: F5,45=
20.109, P<0.001; Fig. 4c, d) of all mice treated with
vehicle. However, the magnitude of such increase in the
FC varied between the two genotypes (interaction
between effects of time and genotype: F5,45=3.171, P<
0.05; main effect of genotype: F1,9=190.114, P<0.001).
In fact, in the FC of wt mice (Fig. 4a) treated with vehicle,
the 5-HT levels reached 1.21 ng/ml 60 min after the
beginning of K
+-stimulation (287% of basal values) while
the peak of extracellular 5-HT levels in FAAH
−/− mice
(Fig. 4b) treated with vehicle was 2.54 ng/ml (127% of
basal values) at the same time point.
In contrast, hippocampal 5-HT release (Fig. 4c, d)
increased to the same extent in vehicle-treated mice of both
genotypes (+228% of basal values in wt mice and +261% in
FAAH
−/− mice).
Surprisingly, the second systemic administration of rimo-
nabant (1 mg/kg, i.p.) given before the K
+-stimulation
Fig. 3 Four-day locomotor
activity (a), rearing frequency
(b) and rearing duration (c)o f
FAAH
−/− (black squares) and wt
(white squares) mice measured
during the 30-min open field test
(5 min per point) performed
under dim light condition. Data
are expressed as mean±SEM
(n=12–15 per group). *P<0.05
(two-way ANOVA for repeated
measures: main effect of
genotype)
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outflowbothintheFC(maineffectoftime:F5,55=29.774, P<
0.001; interaction between effects of time and treatment:
F5,55=13.943, P<0.001; main effect of treatment: F1,11=
5.050, P<0.05; Fig. 4b) and in the vHIPP (main effect of
time: F5,55=8.540, P<0.01; interaction between effects of
time and treatment: F5,55=1.533, n.s.; main effect of
treatment: F1,11=9.528, P<0.05; Fig. 4d) of FAAH
−/− mice.
Conversely, in wt mice, the second administration of
rimonabant did not modify K
+-induced 5-HT release in the
FC (main effect of time: F5,50=31.111, P<0.001; Fig. 4a)a n d
vHIPP (main effect of time: F5,45=16.114, P<0.01; Fig. 4c).
Discussion
In this study, we provide evidence (across social and
nonsocial tests) that, compared to wt counterparts, FAAH
−/−
mice exhibit lower anxiety levels, regardless of the
experimental conditions, and show constitutively higher 5-
HT-ergic tone in the FC, an important area for the control of
mood and emotion.
Interactions between experimental conditions and endo-
cannabinoid modulation have been often reported in a
variety of behavioural paradigms aiming to test the effects
of CB1 activation or blockade on rodent anxiety (Haller et
al. 2004a, b, 2009; Hill and Gorzalka 2004; Martin et al.
2002; Naidu et al. 2007; Patel et al. 2004, 2005; Naderi et
al. 2008).
In our experiments, the emotional phenotype of FAAH
−/−
mice was observed both in the open field and the social
interaction tests. The experimental context was varied by
changing the illumination intensity, and the lower emotional
reactivity of mutant mice prevailed under either dim or bright
light condition. In particular, FAAH
−/− mice showed higher
locomotor and rearing activity and reduced thigmotaxis in
Fig. 4 Effects of vehicle (veh) and rimonabant (rim) administrations on
the basal and K
+-stimulated (horizontal black line) 5-HT extracellular
levels in the FC (a, b) and vHIPP (c, d) of wt (panel a, c)a n dF A A H
−/−
(b, d)f r e e l ym o v i n gm i c e .Arrows indicate the time of vehicle or
rimonabant administrations. Data are expressed as mean±SEM (n=5–7
per group). *P<0.05, **P<0.01 vs last basal wt veh; °P<0.05 and
°°P<0.01 vs last basal wt rim;
#P<0.05 and
##P<0.01 vs last basal
FAAH
−/− veh (Dunnett’s multiple comparison test). Please note that
different scale units were used in b due to the much higher basal 5-
HT levels in FAAH
−/− mice
472 Psychopharmacology (2011) 214:465–476the open field test; they as well spent a greater time engaged
in active interaction in the social interaction test. An increase
in social interaction is generally considered indicative of
reduced anxiety when not concomitant with an increase in
motor activity (File and Seth 2003). Therefore, the higher
locomotor activity observed in FAAH
−/− mice tested in the
open field raised the hypothesis that their increased social
interaction might be a mere consequence of general
hyperactivity rather than the expression of reduced emo-
tionality. To exclude this possibility, we repeatedly moni-
tored mouse motor activity in the open field for four
consecutive days over a 30-min session each day. The
results demonstrated that FAAH
−/− mice were slightly
hyperkinetic only on the first day, when motor activity is
thought to be the net result of exploration drive and anxiety-
like inhibition of the animal in a novel environment
(Denenberg 1969). In fact, on subsequent days, when
exploratory behaviour is less influenced by fear, the
difference between genotypes completely disappeared.
Moreover, in the social interaction test, we observed that
the latency to the first social contact was similar in all groups
of animals, thus further suggesting no difference in motor
capacities between the two genotypes.
Several studies have repeatedly demonstrated that the
pharmacological facilitation of endocannabinoid signal-
ling produces anxiolytic effects in rodents (for review,
see Gaetani et al. 2003, 2009;H i l le ta l .2009). In most
cases, these effects are paralleled by an increased 5-HT
neuron firing activity in the raphe nuclei, the major source
of 5-HT neurons. In line with these evidences, previous
studies showed that FAAH-null mice exhibit an endophe-
notypic augmentation of spontaneous 5-HT neuronal
discharge activity (Bambico et al. 2009) and recent
observations on the same mice reported desensitized 5-
HT2A/2C receptors in the prefrontal cortex (Bambico et al.
2010).
In the present study, we found that FAAH
−/− mice have a
fourfold higher 5-HT extracellular level in the FC, with
respect to wt mice, a trait evident under both basal and K
+-
stimulated conditions.
A down-regulation of 5-HT2A/2C receptors in the
prefrontal cortex appears consistent with the behavioural
profile of FAAH
−/− mice and with the enhanced 5-HTergic
tone observed in their FC. In support of this hypothesis, it is
known that the anti-anxiety effects produced by chronic
administration of selective serotonin reuptake inhibitors are
related to the increase of 5-HT transmission and the down-
regulation of 5-HT2A/2C receptors in the prefrontal cortex
(Yamauchi et al. 2004, 2006).
Differently from the FC observation, we did not detect
any difference between genotypes when we measured 5-HT
outflow in the vHIPP either in basal or K
+-stimulated
conditions.
Based on these observations and considering the
assumption that 5-HT release and activation of 5-HT2C
receptors in the vHIPP are associated with increased anxiety-
like behaviour (Alves et al. 2004; Rex et al. 2005) while
lesions of the vHIPP have anxiolytic effects (Bannerman et
al. 2003; Degroot and Treit 2004), we hypothesize that the
reduced emotionality observed in FAAH null mice might
mostly depend on their higher 5-HT-ergic tone in FC. A
support to this hypothesis can be found in previous
microinjection studies revealing that low doses of the
FAAH inhibitor URB597 produce anxiolytic-like effects
in rats when injected in the prefrontal cortex (Rubino et al.
2008), but not in the vHIPP (Roohbakhsh et al. 2009). In
keeping with our hypothesis, it has been proven that
stimulation of CB1 receptors within the FC increases the
activity of 5-HT neurons in the dorsal raphe through a
multi-synaptic circuit (for review, see Hill et al. 2009) and,
in turn, the 5-HT interaction with 5-HT(2)-type receptors is
able to evoke endocannabinoid release (Best and Regehr
2008). Therefore, we might speculate that the hyper-
activation of CB1 receptors within the FC of FAAH
−/−
mice might account for the enhanced 5-HT activity
observed in their dorsal raphe (Bambico et al. 2009)a s
well as the higher 5-HT levels observed in their FC. In fact,
based on the similarity between the effects of inhibitors of
anandamide hydrolysis and the observations made on
FAAH
−/− mice, the behavioural and neurochemical pheno-
type of these mice appears compatible with their constitu-
tively elevated levels of anandamide in the brain. Therefore,
it is reasonable to suppose that an increased activation of
CB1 receptors can induce in these mice an enhancement of
stress-coping behaviours and a tonic increase of 5-HT
outflow in the FC.
In accordance with the hypothesis of CB1 hyperactiva-
tion, the distinct behavioural phenotype of FAAH
−/− mice
in our tests was completely abolished by the systemic
administration of the CB1 antagonist rimonabant. Surpris-
ingly, rimonabant treatment caused an increase of thigmo-
taxis and grooming behaviour in FAAH
−/− mice subjected
to the open field test under dim light, without affecting both
behaviours in wt mice, thus suggesting a hypersensitivity of
mutant mice toward the anxiogenic effects produced by the
blockade of CB1 receptors. The hypersensitivity of
FAAH
−/− mice to rimonabant effects was even more
evident in our microdialysis study at the beginning of
K
+-stimulation when we detected a dramatic drop of 5-HT
outflow both in the FC and vHIPP following the adminis-
tration of rimonabant at a dose (1 mg/kg) completely
ineffective in wt mice.
This observation is in accordance with the results
obtained in rats repeatedly treated with the FAAH inhibitor
URB597, in which an increased 5-HT neuronal firing
activity was observed and an acute rimonabant administra-
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control levels (Di Marzo et al. 2008). Paradoxically, a few
previous studies have also reported a moderately increased
5-HT efflux in the rat FC after the administration of
rimonabant (Tzavara et al. 2003) and increased 5-HT
extracellular level in the prefrontal cortex of mice lacking
CB1 receptor (Aso et al. 2009). In keeping with such
observations, behavioural studies have demonstrated
antidepressant- and anxiolytic-like effects of CB1 receptor
antagonists in rodents (Tzavara et al. 2003; Griebel et al.
2005; Takahashi et al. 2008). However, these few studies
are inconsistent with a large body of evidence demonstrat-
ing that the genetic or pharmacological interruption of CB1
receptor activity results in enhanced anxiety- and
depressive-like signs in rats and mice (Haller et al. 2002,
2004a, b; Marsicano et al. 2002; Martin et al. 2002;
Navarro et al. 1997).
Clinical observations corroborate the preclinical find-
ings. In fact, rimonabant treatment as anti-obesity therapy
was found to be associated with the development of severe
adverse psychiatric events, mainly depression and anxiety
(Christensen et al. 2007), which led to the suspension of
rimonabant trials. Differences in the baseline endocannabi-
noid tone might be involved in determining the opposite
response of 5-HT transmission and emotionality to the
administration of rimonabant in humans and rodents. In
particular, one might hypothesize that the blockade of CB1
receptor can produce a dramatic drop of 5-HT activity and
stress-coping abilities when the endocannabinoid tone is
particularly elevated, while producing no effect or some-
times opposite effects when the endocannabinoid tone is
low. It is noteworthy that there is increasing body of data
for a hyperactivation of the endocannabinoid system in
overweight and obesity disorders, with significant increases
of anandamide plasma levels in obese patients (Engeli et al.
2005) and the prevalence of FAAH 385 A mutant allele
(Sipe, et al. 2010). The increased sensitivity of FAAH-null
mice toward the anxiogenic effects of rimonabant is further
supportive of our hypothesis.
It is reasonable to speculate that the blockade of CB1
receptor in a condition of elevated anandamide tone might
unmask the action of this molecule on a different cellular
target. For example, besides CB1 receptors, a large body of
evidence now exist to substantiate the concept that
anandamide plays an important role in the modulation of
the transient receptor potential vanilloid type 1 (TRPV1) in
both the central and peripheral nervous systems (for review,
see De Petrocellis and Di Marzo 2009). TRPV1 is
expressed in many areas of the brain, including the FC
and the HIPP (Mezey et al. 2000; Sanchez et al. 2001; Tóth
et al. 2005; Cristino et al. 2006), and its activation produces
opposite effects with respect to CB1 activation, including
anxiogenic effects (Aguiar et al. 2009). The binding site for
anandamide at TRPV1 is located on an intracellular domain
(De Petrocellis et al. 2001); thus, if originated from outside
the cell, anandamide should activate CB1 first and TRPV1
later, after cellular reuptake; conversely, if biosynthesized
from inside the cell, anandamide should activate TRPV1
first (De Petrocellis and Di Marzo 2009). However, at least
two main aspects of the system normally limit anandamide
action at TRPV1 receptors. Anandamide has very low
affinity and potency at TRPV1 compared to CB1 receptors
(Ross et al. 2001) and has a short intracellular half-life due
to the rapid enzymatic hydrolysis, mostly catalysed by
FAAH (Piomelli 2003). These two aspects suggest that, in
case of faah gene deletion, the intracellular accumulation of
anandamide might indeed correspond to an activation of
TRPV1 receptors. However, FAAH
−/− mice show several
signs of CB1, rather than TRPV1, hyperactivation by
anandamide (Cravatt et al. 2001; Varvel et al. 2007). The
prevalence of CB1-mediated actions in these mice might be
ascribed to the negative modulation of TRPV1 responsive-
ness indirectly mediated by CB1 activation. The α subunit
of the Gi protein coupled to CB1 receptor inhibits adenyl
cyclase activity, resulting in the inhibition of protein kinase
A (PKA) activation, which, in turn, is required for TRPV1
phosphorylation (for review, see Ross 2003). Reduced
PKA-mediated TRPV1 phosphorylation results in the rapid
loss of TRPV1 responsiveness (Bhave et al. 2002;
Mohapatra and Nau 2003, 2005; Mahmud et al. 2009).
The administration of rimonabant in a condition of elevated
anandamide tone, such as in the case of FAAH
−/− mice,
might attenuate the negative control of TRPV1 responsive-
ness, thus sensitizing these receptors to anandamide. The
anxiogenic effects of rimonabant administration observed in
mutant mice, but not in wt mice, are consistent with this
hypothesis, as an increasing body of evidence suggest a
pro-anxiety role of TRPV1 activation mediated by high
anandamide levels in the brain (Rubino et al. 2008).
Moreover, voltage-dependent priming of TRPV1 receptors
is another potent mechanism by which the activation by
anandamide may be enhanced (Ahern and Premkumar
2002). This might explain why in FAAH
−/− mice rimona-
bant administration produced a dramatic drop of 5-HT
outflow in FC and vHIPP perfused in depolarizing
conditions, while it previously did not produce any effect
when administered under basal conditions. The mechanism
responsible for a TRPV1-mediated decrease of 5-HT
release in FC and vHIPP might involve GABA-ergic
neurons, as suggested by the finding that TRPV1 agonists
can potentiate GABA-dependent paired pulse depression
(Al-Hayani et al. 2001) in the CA1 region of the HIPP.
Taken together, our results expand our previous findings
on the pharmacological blockade of FAAH by URB597
(Kathuria et al. 2003; Gobbi et al. 2005), indicating that
anandamide may participate in the regulation of emotional
474 Psychopharmacology (2011) 214:465–476reactivity and 5-HT transmission and that enhanced 5-HT
activity may contribute to the possible therapeutic (antide-
pressant/anxiolytic) properties of FAAH inactivation. The
involvement of TRPV1 activation in the effects produced
by rimonabant on FAAH
−/− mice deserves further inves-
tigations to possibly contribute to unveil the mechanisms
responsible for the adverse psychiatric effects observed in
humans.
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